RJF vs NTRS vs ARES
161 measures in 16 categories, one definition each, computed from filings and market data.
RJF50.6
Raymond James Financial, Inc.
Financial Services · Asset Management
$156.78 −0.37%$30.1B mkt cap
Score DNA
NTRS33.1
Northern Trust Corporation
Financial Services · Asset Management
$165.54 +0.06%$30.3B mkt cap
Score DNA
ARES45.4
Ares Management Corporation
Financial Services · Asset Management
$112.27 −1.53%$36.9B mkt cap
Score DNA
Price, rebased to 100 three years ago
RJF NTRS ARES · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 2 | 0 |
| Insider $ bought, 180d | — | $0.08M | — |
| Congress purchases, 180d | 0 | 0 | 1 |
| Last Congress purchase | — | — | 2026-07-07 |
| 13F net change in holders | −18 | +65 | +7 |
| ETFs adding shares, 30d | 985 | 982 | 903 |
| ETFs trimming, 30d | 1,017 | 893 | 652 |
| Net ETF funds, 30d | −32 | +89 | +251 |
Valuation
16 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| P/E (TTM) | 13.1x
48th
|
13.5x
51st
|
58.4x
95th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.01
55th
|
0.49
23rd
|
1.81
70th
|
| Price / sales | 1.8x
15th
|
2.0x
21st
|
5.9x
79th
|
| Price / book | 2.4x
67th
|
2.3x
64th
|
9.3x
89th
|
| Price / tangible book | 2.8x
77th
|
2.5x
71st
|
— |
| Price / free cash flow | 13.3x
65th
|
231.0x
96th
|
44.0x
90th
|
| Price / operating cash flow | 12.2x
67th
|
57.2x
94th
|
40.0x
90th
|
| Enterprise value | $15.7B
76th
|
−$5.7B
2nd
|
$49.9B
88th
|
| EV / sales | 0.9x
0th
|
— | 8.0x
56th
|
| EV / EBITDA | 5.0x
12th
|
— | 21.3x
84th
|
| EV / EBIT | 5.3x
11th
|
— | 23.2x
86th
|
| EV / free cash flow | 6.9x
22nd
|
— | 59.5x
91st
|
| Earnings yield | 7.7%
64th
|
7.4%
61st
|
1.7%
25th
|
| FCF yield | 7.5%
47th
|
0.4%
22nd
|
2.3%
26th
|
| Operating cash flow yield | 8.2%
44th
|
1.7%
21st
|
2.5%
23rd
|
| Graham number (per share) | $130.17
86th
|
$140.61
87th
|
$33.16
59th
|
Profitability (TTM)
12 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Gross margin | 83.5%
76th
|
59.8%
17th
|
62.7%
22nd
|
| EBITDA margin | 18.6%
19th
|
25.7%
29th
|
37.7%
44th
|
| Operating margin | 17.4%
23rd
|
19.8%
28th
|
21.4%
32nd
|
| EBIT margin | 17.4%
23rd
|
19.8%
30th
|
34.6%
54th
|
| Net margin | 13.6%
42nd
|
14.8%
45th
|
10.2%
38th
|
| NOPAT margin | 13.6%
22nd
|
14.7%
24th
|
17.9%
33rd
|
| FCF margin | 13.4%
30th
|
0.9%
21st
|
13.5%
32nd
|
| Operating cash flow margin | 14.6%
30th
|
3.5%
19th
|
14.9%
31st
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 63.0%
90th
|
26.9%
81st
|
18.0%
70th
|
| Stock comp / revenue | 2.2%
74th
|
0.0%
0th
|
0.0%
0th
|
| Effective tax rate | 21.7%
75th
|
25.8%
87th
|
16.6%
47th
|
Returns on capital
11 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| ROE (on average equity) | 18.5%
70th
|
17.1%
66th
|
15.0%
62nd
|
| ROA | 2.6%
52nd
|
1.3%
33rd
|
2.2%
48th
|
| ROIC | -135.6%
0th
|
-9.9%
9th
|
6.5%
54th
|
| ROCE | 11.7%
77th
|
1.8%
23rd
|
7.8%
66th
|
| Return on tangible assets | 3.3%
37th
|
1.7%
23rd
|
7.6%
67th
|
| Cash ROIC (OCF / invested capital) | — | — | 5.4%
39th
|
| Gross profitability (GP / assets) | 15.0%
67th
|
5.1%
27th
|
10.9%
60th
|
| ROIC, 3-yr average | — | — | 4.1%
35th
|
| ROIC, 5-yr average | — | — | 3.8%
31st
|
| ROE, 5-yr average | 17.2%
78th
|
13.5%
61st
|
17.5%
79th
|
| Incremental ROIC | 32.3%
63rd
|
-244.3%
5th
|
72.0%
77th
|
Growth
17 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Revenue growth (TTM YoY) | 9.1%
39th
|
3.1%
25th
|
45.4%
76th
|
| Revenue growth (QoQ) | 2.3%
38th
|
11.3%
62nd
|
-19.1%
22nd
|
| Revenue CAGR, 3 yr | 11.1%
44th
|
15.5%
55th
|
25.3%
75th
|
| Revenue CAGR, 5 yr | 13.0%
70th
|
19.5%
86th
|
20.8%
90th
|
| Gross profit CAGR, 3 yr | 8.3%
21st
|
10.3%
25th
|
25.2%
61st
|
| Operating income CAGR, 3 yr | 8.4%
39th
|
23.5%
71st
|
50.7%
86th
|
| Net income growth (TTM YoY) | 8.1%
41st
|
29.3%
57th
|
44.1%
63rd
|
| Net income CAGR, 3 yr | 9.8%
53rd
|
22.6%
67th
|
43.0%
83rd
|
| EPS growth (TTM YoY) | 12.7%
48th
|
35.2%
62nd
|
33.3%
61st
|
| EPS CAGR, 3 yr | 12.9%
56th
|
27.4%
71st
|
32.2%
80th
|
| EPS CAGR, 5 yr | 15.9%
87th
|
14.7%
83rd
|
13.6%
82nd
|
| FCF growth (TTM YoY) | 16.3%
48th
|
-92.5%
0th
|
-79.0%
5th
|
| FCF CAGR, 3 yr | — | -61.4%
0th
|
— |
| Operating cash flow CAGR, 3 yr | — | -43.9%
2nd
|
— |
| Book value CAGR, 3 yr | 11.6%
72nd
|
9.0%
61st
|
23.4%
88th
|
| Dividend CAGR, 3 yr | 20.0%
96th
|
4.5%
68th
|
-4.6%
38th
|
| Sustainable growth rate | 13.3%
75th
|
12.2%
71st
|
-28.4%
3rd
|
Margin history & stability
7 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Gross margin, 3-yr average | 85.4%
87th
|
54.9%
25th
|
54.1%
23rd
|
| Operating margin, 3-yr average | 17.5%
21st
|
16.4%
19th
|
21.5%
24th
|
| Net margin, 3-yr average | 13.6%
30th
|
12.4%
28th
|
11.1%
24th
|
| FCF margin, 3-yr average | 13.0%
33rd
|
12.7%
31st
|
32.7%
56th
|
| Revenue stability (0-1) | 1.00
97th
|
0.89
77th
|
0.84
72nd
|
| Earnings stability (0-1) | 0.99
100th
|
0.65
77th
|
0.65
76th
|
| Margin stability (0-1) | 0.94
86th
|
0.70
35th
|
0.90
74th
|
Liquidity (latest quarter)
7 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Cash & short-term investments | $19.7B
94th
|
$51.8B
98th
|
$1.9B
79th
|
| Net cash (− = net debt) | $14.4B
97th
|
$36.0B
98th
|
−$13.0B
8th
|
| Working capital | −$44.2B
0th
|
$41.4B
99th
|
−$391.2M
9th
|
| Current ratio | 0.36
22nd
|
4.99
79th
|
0.83
35th
|
| Quick ratio | 0.36
22nd
|
4.99
79th
|
0.83
35th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.29
35th
|
4.99
81st
|
0.83
58th
|
| Defensive interval (days) | 809 days
79th
|
3,114 days
92nd
|
354 days
44th
|
Leverage & solvency (latest quarter)
13 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Total debt | $5.3B
77th
|
$15.8B
90th
|
$14.9B
88th
|
| Debt / equity | 0.42
25th
|
1.18
63rd
|
3.75
95th
|
| Net debt / equity | −1.13
3rd
|
−2.69
1st
|
3.28
95th
|
| Debt / assets | 5.6%
15th
|
8.8%
18th
|
50.2%
72nd
|
| Debt / capital | 29.4%
25th
|
54.1%
63rd
|
78.9%
95th
|
| Debt / EBITDA | 1.68
27th
|
4.04
46th
|
6.36
61st
|
| Net debt / EBITDA | −4.57
4th
|
−9.22
2nd
|
5.56
64th
|
| Interest coverage (EBIT / interest) | 3.4x
64th
|
0.5x
21st
|
2.9x
57th
|
| Cash interest coverage | 2.8x
46th
|
0.1x
17th
|
1.3x
32nd
|
| Debt payback (years of OCF) | 2.1 yrs
29th
|
29.8 yrs
90th
|
16.1 yrs
83rd
|
| Liabilities / assets | 86.5%
92nd
|
92.5%
94th
|
71.0%
82nd
|
| IS credit model rating | BB+ | B+ | B- |
| Implied credit spread (bps) | 400
39th
|
650
60th
|
900
79th
|
Efficiency
11 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Asset turnover | 0.19
65th
|
0.09
31st
|
0.22
68th
|
| Fixed asset turnover | 13.48
60th
|
33.92
79th
|
9.79
51st
|
| Inventory turnover | — | — | — |
| Receivables turnover | 5.4
32nd
|
— | 9.8
53rd
|
| Days sales outstanding | 67 days
70th
|
0 days
0th
|
37 days
50th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 407 days
94th
|
0 days
0th
|
61 days
53rd
|
| Cash conversion cycle (days) | −340 days
7th
|
0 days
55th
|
−24 days
39th
|
| Capex / revenue | 1.2%
82nd
|
2.6%
92nd
|
1.3%
85th
|
| Capex / depreciation | 0.96
85th
|
0.45
78th
|
0.43
77th
|
| Operating expense ratio | 49.0%
57th
|
38.9%
46th
|
0.0%
0th
|
Cash flow & earnings quality
7 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Operating cash flow / net income | 1.07
47th
|
0.24
20th
|
1.46
62nd
|
| FCF / net income | 0.99
50th
|
0.06
20th
|
1.33
66th
|
| FCF / operating cash flow | 92.0%
18th
|
24.8%
5th
|
91.0%
16th
|
| Capex / operating cash flow | 8.0%
85th
|
75.2%
95th
|
9.0%
87th
|
| Accruals ratio | -0.2%
63rd
|
1.0%
71st
|
-1.0%
56th
|
| Sloan accruals ratio | -0.5%
48th
|
61.7%
98th
|
5.9%
81st
|
| Earnings quality score (0-1) | 1.00
60th
|
0.25
0th
|
1.00
60th
|
Scores & forensic checks
15 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| IS score | 51
60th
|
33
18th
|
45
50th
|
| IS profitability | 58
48th
|
64
54th
|
38
24th
|
| IS growth | 53
49th
|
60
62nd
|
77
82nd
|
| IS value | 71
57th
|
78
63rd
|
38
6th
|
| IS momentum | 75
67th
|
54
42nd
|
100
92nd
|
| IS risk (safety) | 15
6th
|
15
6th
|
15
6th
|
| IS quality | 76
82nd
|
58
41st
|
50
32nd
|
| IS balance sheet | 59
78th
|
59
76th
|
23
6th
|
| IS earnings quality | 70
53rd
|
70
58th
|
98
100th
|
| IS cash flow | 63
39th
|
9
8th
|
49
32nd
|
| Piotroski F-score (0-9) | 7
74th
|
8
93rd
|
6
49th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −5.64
93rd
|
−6.70
71st
|
−6.97
56th
|
| IS credit score | 50
61st
|
31
35th
|
23
17th
|
Size (TTM)
8 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| Market cap | $30.1B
86th
|
$30.3B
87th
|
$36.9B
89th
|
| Revenue | $16.9B
90th
|
$15.2B
86th
|
$6.2B
81st
|
| EBITDA | $3.1B
86th
|
$3.9B
88th
|
$2.3B
84th
|
| Net income | $2.3B
91st
|
$2.2B
89th
|
$630.8M
73rd
|
| Free cash flow | $2.3B
93rd
|
$131.1M
42nd
|
$838.1M
69th
|
| Total assets | $94.2B
84th
|
$179.3B
86th
|
$29.6B
81st
|
| Shareholders' equity | $12.7B
87th
|
$13.4B
88th
|
$4.0B
73rd
|
| Employees | 19,500
88th
|
23,800
90th
|
4,343
65th
|
Price performance
9 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| 1 day | −0.4% | +0.1% | −1.5% |
| 1 week | −1.0% | −1.6% | −4.2% |
| 1 month | −3.9% | −6.4% | −10.4% |
| 3 months | −6.5% | −9.4% | −7.4% |
| 6 months | +4.0% | +4.0% | −4.7% |
| Year to date | −3.1% | +18.9% | −32.5% |
| 1 year | −2.9% | +28.2% | −25.2% |
| 3 years, cumulative | +63.2% | +159.8% | +7.2% |
| 5 years, cumulative | +74.9% | +63.8% | +63.9% |
Technicals
4 measures| Measure | RJF | NTRS | ARES |
|---|---|---|---|
| RSI 14 | 37.1 | 34.6 | 32.1 |
| From 52-week high | −13.9% | −15.4% | −37.6% |
| From 52-week low | +13.7% | +37.5% | +18.8% |
| Beta | 0.95 | 1.25 | 1.55 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17